Suchergebnisse - "Karadurmus, Nuri"

PubPharm (150)

1

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2024

von Karadurmuş, N. | Ökten, �. | Türk, H. | +25

2

High dose chemotherapy and autologous stem cell transplantation for salvage therapy of relapsed /refractory germ cell tumors; a single center experience

enthalten in: Oncology research and treatment | 2024

von Yıldıran Keskin, G. | Ertürk, I. | Aykan, M. | +7

3

Genetic testing and counseling challenges in personalized breast cancer care : review article with insights from Türkiye

enthalten in: Future oncology (London, England) | 2024

von Cicin, I. | Karadurmus, N. | Bilici, A. | +9

4

Adrenocortical Cancer in the Real World : A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG)

enthalten in: Clinical genitourinary cancer | 2024

von Yasar, H. | Aktas, B. | Ucar, G. | +30

5

Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases

enthalten in: Scientific reports | 2024

von Kahraman, S. | Karakaya, S. | Kaplan, M. | +44

6

The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors : A Turkish oncology group ( TOG) study

enthalten in: Cancer Medicine | 2024

von Guven, D. | Aykan, M. | Muglu, H. | +16

7

Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007) : A Randomized, Double-Blind, Phase 3 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Yang, J. | Han, B. | De La Mora Jiménez, E. | +16

8

The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors : A Turkish oncology group (TOG) study

enthalten in: Cancer medicine | 2023

von Guven, D. | Aykan, M. | Muglu, H. | +16

9

Safety of lorlatinib in ALK-positive non-small-cell lung cancer and management of central nervous system adverse events

enthalten in: Future oncology (London, England) | 2023

von Kilickap, S. | Ak, S. | Dursun, O. | +3

10

Major and minor salivary gland cancers : A multicenter retrospective study

enthalten in: Head & neck | 2023

von Hacioglu, M. | Erdogan, B. | Bardakcı, M. | +56

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]